Trending...
- California: Governor Newsom announces appointments 9.10.25 - 289
- John Thomas calls for unity and prayer after tragic loss - 265
- Ayurveda, Ayurvedic medical Science and Ayurvedic Therapies, Dr.Abhay Kumar Pati - 255
THOUSAND OAKS, Calif., June 12, 2024 ~ Omeat, a leading biotechnology company, has recently released a white paper detailing the success of their product, Plenty. This nutrient-rich supplement is a humane and cost-effective replacement for Fetal Bovine Serum (FBS), commonly used in cell culture.
Plenty was first launched last year as an ethical alternative to FBS. It is derived from the plasma of living cows and is enriched with platelet lysate, which contains regenerative growth factors. These factors play a crucial role in organ regeneration and cell growth and differentiation.
One of the major advantages of Plenty is its affordability. The process of collecting enriched plasma from cows is more efficient and humane compared to the traditional method of collecting FBS, which involves the slaughter of pregnant cows and their fetuses. This not only makes Plenty more cost-effective but also adheres to high animal welfare standards.
The white paper released by Omeat includes results from independent studies conducted by prestigious research universities worldwide. These studies have shown that Plenty's performance is comparable to or even surpasses that of FBS in supporting cell growth in 15 different cell lines. This validates Plenty's efficacy and reliability as a cell culture supplement.
More on The Californer
Some of the institutions that have evaluated Plenty include Stanford University, Boston University, Emory University, Syracuse University, Johns Hopkins University, UCLA, Virginia Tech, Northeastern University, and Universitätsklinikum Erlangen. With such positive results from reputable sources, Plenty has the potential to revolutionize various industries and research fields such as drug discovery, cancer research, and neurodegenerative disease studies.
Plenty can be purchased directly from http://getplenty.bio at an introductory price of $200 per 500mL bottle and $50 per 60mL sample. These prices are significantly lower than those of FBS, making it an attractive option for researchers and companies alike.
Omeat's commitment to animal welfare is evident in their selection of cows that are free of zoonotic diseases and allowed to graze freely on a large pasture. This eliminates the need for environmentally destructive feedlots, making Plenty a sustainable and ethical choice.
With its proven success and ethical production process, Plenty has the potential to be a game-changer in the world of cell culture. Researchers and companies can now have access to a cost-effective and humane alternative to FBS, thanks to Omeat's innovative product.
Plenty was first launched last year as an ethical alternative to FBS. It is derived from the plasma of living cows and is enriched with platelet lysate, which contains regenerative growth factors. These factors play a crucial role in organ regeneration and cell growth and differentiation.
One of the major advantages of Plenty is its affordability. The process of collecting enriched plasma from cows is more efficient and humane compared to the traditional method of collecting FBS, which involves the slaughter of pregnant cows and their fetuses. This not only makes Plenty more cost-effective but also adheres to high animal welfare standards.
The white paper released by Omeat includes results from independent studies conducted by prestigious research universities worldwide. These studies have shown that Plenty's performance is comparable to or even surpasses that of FBS in supporting cell growth in 15 different cell lines. This validates Plenty's efficacy and reliability as a cell culture supplement.
More on The Californer
- Marin's Rising Star Easton Cain Revives American Regionalism in the Bay Area
- City of Long Beach Launches Redesigned Jobs Webpage
- Cabrillo Economic Development Corporation Celebrates Completion of Dolores Huerta Gardens
- Lightning Motorcycle's Next-Gen Prototype Hits 174 MPH on Its Lowest Performance Setting
- Long Beach Health Department Launches Early Childhood Mental Health Program to Support Families and Childcare Providers
Some of the institutions that have evaluated Plenty include Stanford University, Boston University, Emory University, Syracuse University, Johns Hopkins University, UCLA, Virginia Tech, Northeastern University, and Universitätsklinikum Erlangen. With such positive results from reputable sources, Plenty has the potential to revolutionize various industries and research fields such as drug discovery, cancer research, and neurodegenerative disease studies.
Plenty can be purchased directly from http://getplenty.bio at an introductory price of $200 per 500mL bottle and $50 per 60mL sample. These prices are significantly lower than those of FBS, making it an attractive option for researchers and companies alike.
Omeat's commitment to animal welfare is evident in their selection of cows that are free of zoonotic diseases and allowed to graze freely on a large pasture. This eliminates the need for environmentally destructive feedlots, making Plenty a sustainable and ethical choice.
With its proven success and ethical production process, Plenty has the potential to be a game-changer in the world of cell culture. Researchers and companies can now have access to a cost-effective and humane alternative to FBS, thanks to Omeat's innovative product.
Filed Under: Business
0 Comments
Latest on The Californer
- WesternU researchers show Osteopathic Manipulative Treatment improves efficacy of COVID-19 vaccine
- Vesica Health Receives AUA Guideline Inclusion
- Steward's Plumbing Sponsors the 2025 Samson Challenge, Bringing Community, Fitness, and Fun Together in Albuquerque
- Machine Vision Products Unveils New Homepage at Visionpro.com
- Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences
- California: Governor Newsom proclaims Latino Heritage Month
- MEDIA ALERT: Cisco's WebexOne Event Spotlights Global AI Brands and Ryan Reynolds, Acclaimed Actor, Film Producer, and Entrepreneur
- Patrick Perez Steps Beyond Crunchyroll to Shape the Next Wave of Streaming & Media Innovation
- Mesa West Capital Originates $43.5 Million Loan to Refi LA Area Apartment Community
- 10xLaw.com Extends Employment Opportunity to Kim Kardashian
- DecisionPoint Technologies Accelerates Growth with Acquisition of Acuity Technologies
- CCHR: Involuntary Commitment Is Eugenics Repackaged as "Mental Health Care"
- Pacsun Announces Industry First Pacsun Youth Advisory Council: Empowering Its Consumers as Co-Creators in Brand Strategy
- Q2 2025 Industry Impact Report Underscores Semiconductor Expansion, Talent Development and Sustainability Milestones
- 84 Ethiopian Churches Change Signboards to Shincheonji Church of Jesus
- BTXSGG Outlines Four-Pillar Framework to Enhance Digital Asset Security and Compliance
- NJTRX Positions for Next-Generation Asset Trading with U.S. Regulatory Framework
- America's SBDC Announces 2025-2026 Board of Directors
- Avoid Swirl Marks When You Get a Car Wash in Downey CA
- Freedom Flourishes in Dutch Capital on Destination: Scientology, Amsterdam